Skip to main content
. 2021 Jan 12;14(3):101014. doi: 10.1016/j.tranon.2021.101014

Fig. 4.

Fig 4:

Correlation of immunological biomarkers with relapse free survival. Higher levels of CD8+ central memory cells at baseline were associated with 12-month relapse free survival (P = 0.0098). On the other hand, higher levels of CD8+ TIM3+ cells was associated with worse relapse-free survival (p = 0.074).